

MONETARY Next ECB QE extension (Dec)
MONETARY Global central banks
FISCAL Next US fiscal package (Q4/ H1-21)

FISCAL EU Recovery Fund (Q1-21)



MEDICAL Search for vaccine

TRADE US–China trade tensions
MEDICAL Covid-19 virus
TRADE UK–EU trade negotiations (Nov/Dec)
Contact us
Thank you for reading our monthly update. Please contact us if you have any questions, remarks or suggestions regarding this update.
WE TAKE TIME TO LISTEN
Counterpoint December 2020
Back to top
This document has been prepared by Quintet Private Bank (Europe) S.A. The statements and views expressed in this document based upon information from sources believed to be reliable – are those of Quintet Private Bank (Europe) S.A. as of 20 November 2020 and are subject to change. This information is defined as non-independent research because it has not been prepared in accordance with the legal requirements designed to promote the independence of investment research, including any prohibition on dealing ahead of the dissemination of this information. This document is of a general nature and does not constitute legal, accounting, tax or investment advice. This document does not provide any individual investment advice and an investment decision must not be based merely on the information and data contained in the document. All investors should keep in mind that past performance is no indication of future performance, and that the value of investments may go up or down. Changes in exchange rates may also cause the value of underlying investments to go up or down.
Copyright © Quintet Private Bank (Europe) S.A. 2020.
All rights reserved. Privacy Statement
Invest in a richer life,
however you define it.

The asset allocation vector
Click an asset class to show the sub-asset classes



We’re more confident about the path of the recovery now that the beginning of the end of the virus crisis is in sight
A positive outlook
Quintet portfolio
setback over the winter due to ongoing lockdowns.
We believe the macro backdrop supports equities over bonds, while price momentum on US stocks is positive and improving. In addition, the third-quarter earnings season confirmed that many US companies are on track for a healthy recovery of profits. The rather balanced sector mix between defensives and cyclicals, coupled with a large weight in the structurally supported technology sector, leaves US equities well-positioned.
More on our views
During the third quarter we dialled down risk in portfolios to reflect slowing economic growth, heightened political risk and reduced visibility about the immediate outlook. Successful Covid-19 vaccine trials and the aftermath of the US election allow us to look ahead to 2021 with more certainty, and we’ve adjusted our asset allocation to reflect our confidence.
Notably, we’ve increased our exposure to risk in portfolios by overweighting US equities, which we believe have the potential to outperform investment grade corporate bonds in today’s environment of low yields. Although it’s still early days, the path of the recovery is now more certain, even though the economy could suffer a temporary
"we believe we can look through these short-term headwinds to next spring"


Successful Covid-19 vaccine trials have cheered financial markets as investors look through what’s likely to be a challenging winter for the economy
A shot in the arm
COUNTERPOINT DECEMBER 2020
Monitor
Portfolio
Investment focus
Top chart
Welcome






Scroll down

Welcome
A new hope
What a difference a month can make

The high success rates of Covid-19 vaccine trials have raised hopes of a quicker recovery than previously expected. Although there are still huge challenges ahead in terms of deployment, the beginning of the end seems to be on the horizon. The news has excited stock markets, and triggered a powerful rotation into economically sensitive sectors. This shift is also a reflection of the increased likelihood that company profits and lifestyles will return to normal in 2021.
As we look forward to better days ahead, we remain committed to supporting the transition to a greener economy. There are lots of things we can do as individuals to reduce our carbon footprint, such as changing what we eat and how we travel. As investors, we can channel capital to innovative projects and technologies. To find out more about our efforts to improve the environment, watch the highlights from our recent webinar ‘For a richer planet: carbon reduction and the role humans play’.
Bill Street
Group Chief Investment Officer
Source: Quintet, Oxford COVID-19 Government Response Tracker (OxCGRT)

Our lives are restricted again, but our economy has adapted
Lockdown light
Top chart
This stringency index records the strictness of lockdowns. Although many countries have re-imposed restrictions on socialising and travel, the measures are more moderate than they were at the start of the coronavirus crisis. Notably, it appears that our
economies have adapted, so that the impact on activity is less pronounced. For example, Google’s Mobility Index has dipped, but not by nearly as much as it did back in March and April.
Read more
The strong results from two late-stage trials of Covid-19 vaccines have fuelled a stock market rally. Yet global coronavirus cases and deaths have continued to soar. In response, national and local governments have reimposed or tightened restrictions on travel and socialising in order to slow the virus’s spread. As a result, economic activity is likely to weaken over the winter, and Europe in particular appears vulnerable to another sharp slowdown.
At this point in the recovery, we need to weigh the worsening coronavirus pandemic against hopes for potential vaccines. The early results are encouraging, although immunising most of the world’s population could prove logistically challenging, while manufacturing and distributing vaccines at scale is likely to take time. However, we believe we can look through these short-term headwinds to next spring, when the recovery should gather momentum as the economy reopens.
Contact us
The US election result provides another reason to look ahead with more confidence by reducing the political uncertainty that has overshadowed markets for much of 2020. Although Joe Biden won the race, there has been no ‘blue wave’ that many expected, where the Democrats would have controlled not just the White House but both houses of Congress too. However, Biden’s behaviour is likely to be more predictable internationally and less disruptive domestically.
In the short term, stock markets have experienced a powerful rotation into economically sensitive sectors, as investors have looked ahead to more solid growth potential on the horizon. Over the longer term they should also continue to be supported by central bank monetary policies, including low interest rates and additional liquidity, as well as government stimulus measures, which include replacing lost incomes with subsidies and transfers.
This document has been prepared by Quintet Private Bank (Europe) S.A. The statements and views expressed in this document based upon information from sources believed to be reliable – are those of Quintet Private Bank (Europe) S.A. as of 20 November 2020 and are subject to change. This information is defined as non-independent research because it has not been prepared in accordance with the legal requirements designed to promote the independence of investment research, including any prohibition on dealing ahead of the dissemination of this information. This document is of a general nature and does not constitute legal, accounting, tax or investment advice. This document does not provide any individual investment advice and an investment decision must not be based merely on the information and data contained in the document. All investors should keep in mind that past performance is no indication of future performance, and that the value of investments may go up or down. Changes in exchange rates may also cause the value of underlying investments to go up or down.
Copyright © Quintet Private Bank (Europe) S.A. 2020.
All rights reserved. Privacy Statement
Invest in a richer life,
however you define it.

Back to top

MONETARY
Next ECB QE extension (Dec)


FISCAL
EU Recovery Fund (Q1-21)

FISCAL
Next US fiscal package (Q4/ H1-21)
MONETARY
Global central banks

MEDICAL
Search for vaccine

MEDICAL
Covid-19 virus

TRADE
US–China trade tensions
TRADE
UK–EU trade negotiations (Nov/Dec)

During the third quarter we dialled down risk in portfolios to reflect slowing economic growth, heightened political risk and reduced visibility about the immediate outlook. Successful Covid-19 vaccine trials and the aftermath of the US election allow us to look ahead to 2021 with more certainty, and we’ve adjusted our asset allocation to reflect our confidence.
Notably, we’ve increased our exposure to risk in portfolios by overweighting US equities, which we believe have the potential to outperform investment grade corporate bonds in today’s environment of low yields. Although it’s still early days, the path of the recovery is now more certain, even though the economy could suffer a temporary setback over the winter due to ongoing lockdowns.
We believe the macro backdrop supports equities over bonds, while price momentum on US stocks is positive and improving. In addition, the third-quarter earnings season confirmed that many US companies are on track for a healthy recovery of profits. The rather balanced sector mix between defensives and cyclicals, coupled with a large weight in the structurally supported technology sector, leaves US equities well-positioned.
"we believe we can look through these short-term headwinds to next spring"

Welcome

The strong results from two late-stage trials of Covid-19 vaccines have fuelled a stock market rally. Yet global coronavirus cases and deaths have continued to soar. In response, national and local governments have reimposed or tightened restrictions on travel and socialising in order to slow the virus’s spread. As a result, economic activity is likely to weaken over the winter, and Europe in particular appears vulnerable to another sharp slowdown.
At this point in the recovery, we need to weigh the worsening coronavirus pandemic against hopes for potential vaccines. The early results are encouraging, although immunising most of the world’s population could prove logistically challenging, while manufacturing and distributing vaccines at scale is likely to take time. However, we believe we can look through these short-term headwinds to next spring, when the recovery should gather momentum as the economy reopens.

This stringency index records the strictness of lockdowns. Although many countries have re-imposed restrictions on socialising and travel, the measures are more moderate than they were at the start of the coronavirus crisis. Notably, it appears that our economies have adapted, so that the impact on activity is less pronounced. For example, Google’s Mobility Index has dipped, but not by nearly as much as it did back in March and April.
The high success rates of Covid-19 vaccine trials have raised hopes of a quicker recovery than previously expected. Although there are still huge challenges ahead in terms of deployment, the beginning of the end seems to be on the horizon. The news has excited stock markets, and triggered a powerful rotation into economically sensitive sectors. This shift is also a reflection of the increased likelihood that company profits and lifestyles will return to normal in 2021.
As we look forward to better days ahead, we remain committed to supporting the transition to a greener economy. There are lots of things we can do as individuals to reduce our carbon footprint, such as changing what we eat and how we travel. As investors, we can channel capital to innovative projects and technologies. To find out more about our efforts to improve the environment, watch the highlights from our recent webinar ‘For a richer planet: carbon reduction and the role humans play’.
Successful Covid-19 vaccine trials have cheered financial markets as investors look through what’s likely to be a challenging winter for the economy

A shot in the arm
COUNTERPOINT DECEMBER 2020

Top chart


Bill Street
Group Chief Investment Officer

The asset allocation vector
Click an asset class to show the sub-asset classes
Emerging market sovereign debt / US investment grade bonds
Emerging market sovereign debt offers an additional yield of 3% over US investment grade bonds, and a weaker US dollar and rising oil prices are tailwinds.
US Treasuries / Eurozone government bonds
We have higher conviction in US Treasuries as a diversifier than in European government bonds thanks to their higher yield to maturity and better credit quality.
US Treasury Inflation Protected Securities (US TIPS) / Eurozone government bonds
The difference between the yield of nominal bonds and inflation-linked bonds remains lower than our inflation forecasts, which favours US TIPS.
US equities / US investment grade bonds
We believe US stocks can outperform low-yielding US investment grade bonds at this stage of the business cycle. Ample monetary and fiscal stimulus are supportive.
Emerging market equities / Eurozone government bonds
Emerging market equities are cheaper than developed market equities on long-term valuation measures, and remain supported by strong growth in China.
Gold / Eurozone government bonds
Gold has had a low correlation with other assets and can act as a diversifier. Low real yields are positive for gold. Fading geopolitical risks are a headwind.
European high yield bonds / Eurozone investment grade bonds
European high yield bonds offer an additional yield of 3.5% over European investment grade bonds, and default risks remain subdued.
When we increase the allocation to one asset class in portfolios, we have to decrease the allocation to another. That’s why our tactical asset allocation (TAA) decisions come in pairs, where we underweight and overweight relative to our strategic asset allocation (SAA) weightings. The specific numerical weights from the chart relate to a EUR balanced portfolio and can be adjusted for different profiles.
Our views, in depth
Thank you for reading our monthly update. Please contact us if you have any questions, remarks or suggestions regarding this update.
WE TAKE TIME TO LISTEN
Counterpoint December 2020

Outlook is less certain than last month

Outlook is more certain than last month
While the global health crisis remains the most important issue, risks have receded now the US election is over and following successful Covid-19 vaccine trials
WHAT TO LOOK
OUT FOR
Monitor

We’re more confident about the path of the recovery now that the beginning of the end of the virus crisis is in sight
A positive outlook
Quintet portfolio

The path of the recovery is more certain following successful vaccine trials and the US election results
A more certain outlook
Investment focus


Swipe to see the full graph
Source: Quintet, Oxford COVID-19 Government Response Tracker (OxCGRT)
Our lives are restricted again, but our economy has adapted
Lockdown light
Top chart

What a difference a month can make

A new hope
Welcome
Investment focus


Monitor

Portfolio
